Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

5.0%

3 terminated/withdrawn out of 60 trials

Success Rate

88.0%

+1.4% vs industry average

Late-Stage Pipeline

17%

10 trials in Phase 3/4

Results Transparency

14%

3 of 22 completed trials have results

Key Signals

9 recruiting3 with results

Enrollment reporting

Analytics

N/A
24(61.5%)
Phase 4
7(17.9%)
Phase 2
4(10.3%)
Phase 3
3(7.7%)
Phase 2/3
1(2.6%)
39Total
N/A(24)
Phase 4(7)
Phase 2(4)
Phase 3(3)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (60)

Showing 20 of 60 trials
NCT07028983Not ApplicableRecruiting

Fighting Addictions, Improving Lives: COmprehensive Drug Rehabilitation With Music

Role: collaborator

NCT07851779Phase 4Recruiting

Withdrawal of Heart Failure Treatment Patients With Non-ischemic Cardiomyopathy Who Have Been Super-responders to Cardiac Resynchronization Therapy.

Role: lead

NCT06781294Not ApplicableActive Not Recruiting

SIRAKI 02 Posthoc Analysis.

Role: collaborator

NCT07304752Not ApplicableRecruiting

Effect of Probe Material on Peri-implant Probing

Role: collaborator

NCT06513533Phase 2/3Active Not Recruiting

Dimethyl Fumarate in Adrenomyeloneuropathy

Role: collaborator

NCT07555743Phase 4Not Yet Recruiting

Efficacy and Safety of Daridorexant in Patients With Major Depressive Disorder and Insomnia

Role: lead

NCT04848883Not ApplicableCompleted

Infectious Diseases Experts as Part of the Antibiotic Stewardship Team in Primary Care

Role: lead

NCT07456332Not ApplicableEnrolling By Invitation

Effect on Body Weight Reduction of a Behavioral Intervention on Lifestyle Using a Digital Nutritional Program in People Living With HIV and Metabolic Dysfunction-associated Steatotic Liver Disease

Role: collaborator

NCT07303751Phase 2Not Yet Recruiting

Study Assessing Reduced HPV Infectivity and Transmission in HPV-Positive Women Following Vaccination With 9vHPV

Role: lead

NCT07155590Active Not Recruiting

Subphenotype- and Complication-guided Adjunctive Fosfomycin Therapy for Staphylococcus Aureus Bacteraemia

Role: collaborator

NCT07021235Completed

Proof of Concept of the Aiinane Preoperative Risk Assessment Tool.

Role: collaborator

NCT07058207Not ApplicableRecruiting

Weight Management in Obese Cancer Patients During Curative Active Treatment

Role: lead

NCT07038265Not ApplicableRecruiting

Patient-centered Personalized Cardiac Rehabilitation in Post Acute Coronary Syndrome (BREAK-trial)

Role: lead

NCT07039994Not ApplicableRecruiting

Early Palliative Care in Patients With Advanced Lung Cancer Using an e-Health Ecosystem

Role: collaborator

NCT04899206Withdrawn

ANGIOTENSIN AGENTS AND REDUCTION OF THE PRESCRIPTION OF ANTIDEPRESSANT DRUGS: A RETROSPECTIVE COHORT STUDY USING REAL-WORLD DATA

Role: collaborator

NCT06931899Not Yet Recruiting

Oscillometry in the COPD Exacerbator Phenotype With Triple Inhaled Therapy Study

Role: collaborator

NCT06718322Not ApplicableEnrolling By Invitation

PIECES - Towards Large-Scale Adaptation and Tailored Implementation of Primary Cancer Prevention Programs

Role: collaborator

NCT05523856Active Not Recruiting

New Treatment Modalities for Localized Prostate Cancer

Role: collaborator

NCT06695832Active Not Recruiting

Adjunctive Fosfomycin for Treatment of Staphylococcus Aureus Bacteraemia

Role: collaborator

NCT06499064Not ApplicableUnknown

EOSS-ATTR Study (eHealth Based Operative Support System in ATTR-CM)

Role: collaborator